SCHEMBL3652871

SCHEMBL3652871

O=C(O)C1CCN(CCOc2cc(Nc3ncc(-c4ccc(OC(F)F)cc4)cn3)ccc2F)CC1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 2/20 0.40
▸ EGFR P00533 2/20 0.39
▸ BTK Q06187 2/20 0.39
▸ CSF1R P07333 3/20 0.39
▸ DRD2 P14416 2/20 0.39
▸ AXL P30530 1/20 0.38
▸ MCHR1 Q99705 2/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ SYK P43405 1/20 0.38
▸ EPHX2 P34913 4/20 0.38
▸ DYRK1A Q13627 1/20 0.37
▸ CHRM1 P11229 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ BRAF P15056 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3650361 0.92 CSF1R (0.41) LTA4HEGFRBTKCSF1RDRD2
SCHEMBL3644492 0.89 LTA4H (0.49) LTA4HEGFRDRD2AXLMCHR1
SCHEMBL13472146 0.88 CSF1R (0.42) LTA4HCSF1RDRD2AXLMCHR1
SCHEMBL27785763 0.88 EGFR (0.41) EGFRBTKCSF1RDRD2AXL
SCHEMBL3650367 0.88 EGFR (0.39) EGFRBTKAXLDYRK1ACNR2
SCHEMBL3646162 0.87 EGFR (0.50) LTA4HEGFRBTKDRD2SYK
SCHEMBL3650207 0.84 GPR6 (0.41) EGFRBTKCSF1RJAK2
SCHEMBL3647442 0.83 LTA4H (0.42) LTA4HEGFRBTKCSF1RJAK2
SCHEMBL3652219 0.83 EGFR (0.39) LTA4HEGFRBTKJAK2SYK
SCHEMBL3652561 0.83 EGFR (0.40) EGFRBTKCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101784530-A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC 2010-07-21 — — CN claimed
EP-2190825-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2010-06-02 — — EP claimed
WO-2009026276-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-02-26 — — WO claimed
US-8293757-B2 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC (BM) 2012-10-23 — — US disclosed
US-8293757-B2 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC (BM) 2012-10-23 — — US disclosed
US-8293757-B2 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC (BM) 2012-10-23 — — US disclosed
CN-101784530-A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC 2010-07-21 — — CN disclosed
EP-2190825-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2010-06-02 — — EP disclosed
WO-2009026276-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-02-26 — — WO disclosed
WO-2009026276-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-02-26 — — WO disclosed
Send feedback